Aakha Biologics is a biotechnology company developing first-in-class, multi-specific antibodies for the treatment of solid tumors. The company's platform generates antibodies that efficiently block disease-driver pathways and engage optimal immune activation, offering new hope for patients with limited therapeutic options.
